Correction for Holland Et Al., Subregional Neuroanatomical Change as a Biomarker for Alzheimer's Disease

Proceedings of the National Academy of Sciences of the United States of America- United States

doi 10.1073/pnas.1001505107

Full Text

Abstract

Available in

Date

Authors

Unknown

Publisher

Proceedings of the National Academy of Sciences

Related search

Extravascular Fibrinogen in the White Matter of Alzheimer's Disease and Normal Aged Brains: Implications for Fibrinogen as a Biomarker for Alzheimer's Disease

Brain Pathology
Forensic MedicineNeurosciencePathologyNeurology
2019English

Visuospatial Perception: An Emerging Biomarker for Alzheimer's Disease

Journal of Alzheimer's Disease
GerontologyClinical PsychologyMental HealthPsychiatryGeriatricsMedicineNeuroscience
2012English

Changes in the EEG Amplitude as a Biomarker for Early Detection of Alzheimer's Disease

2016English

ApoE Genotyping as a Progression-Rate Biomarker in Phase II Disease-Modification Trials for Alzheimer's Disease

Pharmacogenomics Journal
Molecular MedicineGeneticsPharmacology
2009English

Correction for Bengoechea Et Al., P75 Reduces -Amyloid-Induced Sympathetic Innervation Deficits in an Alzheimer's Disease Mouse Model

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2009English

Serum Interleukin (IL)-15 as a Biomarker of Alzheimer's Disease

PLoS ONE
Multidisciplinary
2015English

Correction for Nixon Et Al

BMJ
2006English

Evaluation of Annexin A5 as a Biomarker for Alzheimer's Disease and Dementia With Lewy Bodies

Frontiers in Aging Neuroscience
AgingCognitive Neuroscience
2013English

Promise and Challenge: The Lens Model as a Biomarker for Early Diagnosis of Alzheimer's Disease

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy